Riskpilot← Back to searchSign inGet full accessToxicology Knowledge Team Sweden AB
ABActiveOrg 5569024614Forskargatan 20 JBusiness and other management consultancy activities · NACE 7020Est. 201210-19 employees
Revenue 2024
SEK 14,4M
+1% vs 2023
EBITDA margin
16.1%
-27% vs 2023
Equity ratio
59.2%
Financial strength
Net profit 2024
SEK 208K
+617% vs 2023
| Revenue | SEK 14,4M | +1% |
| EBITDA | SEK 2,3M | -27% |
| Net profit | SEK 208K | +617% |
| Total assets | SEK 6,5M | -31% |
| Equity | SEK 3,9M | +6% |
| Employees | — | — |
Legal name
Toxicology Knowledge Team Sweden AB
Org number
5569024614
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
31 augusti 2012
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Iverson Hemberg, Suzanne Leah i förening med en av Meyer, Karin Judith Sjöberg, Bror Folke Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva konsult-, bemanningsverksamhet och riskbedömning inom toxikologi, miljö, farmakologi, läkemedelsutveckling, kosmetika, naturläkemedel, kosmetika, medical devices, kemikalieregistrering, 3R-området (dvs, minskning, förbättring eller ersättning av försökdjursanvändning) , undervisning, dokumentation och kommunikation, farmaceutiska tjänster samt därmed förenlig verksamhet.
Address
Forskargatan 20 J
Email
karin.meyer@ctr-ab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 184 | 10 732 | 10 569 | 14 275 | 14 399 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 610 | 1 270 | 269 | 3 202 | 2 322 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 610 | 1 270 | 269 | 3 202 | 2 322 |
| Net financials | −1 | — | −38 | 68 | 541 |
| Profit before tax | 609 | 955 | 176 | 44 | 212 |
| Tax | −137 | −204 | −45 | −15 | −4 |
| Net profit | 472 | 751 | 131 | 29 | 208 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 798 | 5 193 | 6 302 | 9 431 | 6 524 |
| Equity | 2 740 | 3 491 | 3 622 | 3 651 | 3 859 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 058 | 1 388 | 2 291 | 5 366 | 2 251 |
| Total debt | 1 058 | 1 388 | 2 291 | 5 366 | 2 251 |
EBITDA margin
16.1%
This company
15.8%
Market median
+2% vs market
20202024
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
5.4%
This company
18.4%
Market median
-71% vs market
20202024
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20202024
Asset turnover
2.21×
This company
1.12×
Market median
+97% vs market
20202024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SA Chief Auditor | Chief Auditor | 2020 |
AS Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (3) | ||
LJ | Audit | 2022 – 2023 |
EH Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
KB Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2026 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2026 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Center for Translational Research Sweden AB
Toxicology Knowledge Team Sweden AB Board members of Toxicology Knowledge Team Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Valfrid Grahn | Audit | 0 companies |
| Stéphanie Anna Chantal Ljungberg | Chief Auditor | 0 companies |
| Elinor Hahne Fors | Chief Executive Officer | 0 companies |
| Kerstin Birgitta Kenne | Chief Executive Officer | 0 companies |
| Anna Sofia Steneholm | Chief Executive Officer | 0 companies |
| Suzanne Leah Iverson Hemberg | Chairman | 0 companies |
| Carl-Johan Zettervall | Board of Directors | 0 companies |
| Bengt Erik Dahlström | Board of Directors | 0 companies |
| Karin Judith Meyer | Board of Directors | 0 companies |
| Karin Linnéa Svens | Chairman | 0 companies |
| Eva-Lena Glämsta | Board of Directors | 0 companies |
| Bror Folke Sjöberg | Deputy Board Member | 0 companies |
| Stefan Czene | Board of Directors | 0 companies |